COX-2 and mPGES-1 expression in canine mast cell tumours

• Autorzy: Kandefer-Gola M. , Nowak M. , Dzimira S. , Janus I. , Ciaputa R. , Madej J. A.
• Języki publikacji: EN

Abstrakty

EN

COX-2 and mPGES-1 participate in the development of tumours and play a key role in their progression by impacting cell proliferation, apoptosis and neoangiogenesis. The aim of the study was to assess the expression of COX-2 and mPGES-1 in mast cell tumours. The existence of correlation between the histologic malignancy of the tumour and the expression of the proteins was verified through statistical analysis. Fifteen canine skin mast cell tumours were used in the study. Tissue sections were stained with H&E to determine their histologic grade. Subsequently, immunohistochemical staining of COX-2 and mPGES was carried out. A cytoplasmic reaction was observed in all tumours. Statistical analysis revealed a strong, positive correlation (p < 0.05) between the two markers and the grade of the tumour. Both markers may be used effectively in the diagnosis of skin mast cell tumours in dogs.

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2015
• Tom: 71
• Numer: 06
• Opis fizyczny: p.345-348,fig.,ref.

Twórcy

autor

Kandefer-Gola M.

• Department of Pathology, Division of Pathomorphology and Veterinary Forensics, Faculty od Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, Norwida 31, 50-375 Wroclaw, Poland

autor

Nowak M.

• Department of Pathology, Division of Pathomorphology and Veterinary Forensics, Faculty od Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, Norwida 31, 50-375 Wroclaw, Poland

autor

Dzimira S.

• Department of Pathology, Division of Pathomorphology and Veterinary Forensics, Faculty od Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, Norwida 31, 50-375 Wroclaw, Poland

autor

Janus I.

• Department of Pathology, Division of Pathomorphology and Veterinary Forensics, Faculty od Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, Norwida 31, 50-375 Wroclaw, Poland

autor

Ciaputa R.

• Department of Pathology, Division of Pathomorphology and Veterinary Forensics, Faculty od Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, Norwida 31, 50-375 Wroclaw, Poland

autor

Madej J. A.

• Department of Pathology, Division of Pathomorphology and Veterinary Forensics, Faculty od Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, Norwida 31, 50-375 Wroclaw, Poland

Bibliografia

• 1. Dannenberg A. J., Altorki N. K., Boyle J. O., Dang C., Howe L. R., Weksler B. B., Subbaramaiah K.: Cyclooxygenase-2: a pharmacological target for the prevention of cancer. Lancet Oncol. 2001, 2, 544-551.
• 2. Ghosh N., Chaki R., Mandal V., Mandal S. C.: COX-2 as a target for cancer chemotherapy. Pharmacol. Rep. 2010, 62, 233-244.
• 3. Greenhough A., Smartt H. J. M., Moore A. E., Roberts H. R., Williams A. C., Paraskeva C., Kaidi A.: The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 2009, 30, 377-386.
• 4. Hara S., Kamei D., Sasaki Y., Tanemoto A., Nakatani Y., Murakami M.: Prostaglandin E synthases: Understanding their pathophysiological rolesthrough mouse genetic models. Biochimie 2010, 2, 651-649.
• 5. Heller D. A., Clifford C. A., Goldschmidt M. H., Holt D. E., Manfredi M. J., Sorenmo K. U.: Assessment of Cyclooxygenase-2 Expression in Canine Hemangiosarcoma, Histiocytic Sarcoma, and Mast Cell Tumor. Vet. Pathol. 2005, 42, 50-353.
• 6. Millanta F., Asproni P., Canale A., Citi S., Poli A.: COX-2, mPGES-1 and EP2 receptor immunohistochemical expression in canine and feline malignantmammary tumours. Vet. Comp. Oncol. 2014, doi: 10.1111/vco.12096.
• 7. Millanta F., Asproni P., Cancedda S., Vignoli M., Bacci B., Poli A.: Immunohistochemical expression of COX-2, mPGES and EP2 receptor in normal and reactive canine bone and in canine osteosarcoma. J. Comp. Pathol.2012, 147, 153-160.
• 8. Murakami M., Yoshihara K., Shimbara S., Lambeau G., Gelb M. H., Singer A. G., Sawada M., Inagaki N., Nagai H., Ishihara M., Ishikawa Y., Ishii T., Kudo I.: Cellular arachidonate-releasing function and inflammation-associated expression of group IIF secretory phospholipase A2. J. Biol. Chem. 2002, 277, 19145-19155.
• 9. Oshima H., Oshima M., Inaba K., Taketo M. M.: Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice.EMBO J. 2004, 23, 1669-1678.
• 10. Patnaik A. K., Ehler W. J., MacEwen E. G.: Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet. Pathol. 1984, 21, 469--474.
• 11. Prada J., Queiroga F. L., Gregório H., Pires I.: Evaluation of cyclooxygenase-2 expression in canine mast cell tumours. J. Comp. Pathol. 2012, 147, 31-36.
• 12. Queiroga F. L., Alves A., Pires I., Lopes C.: Expression of Cox-1 and Cox-2 in canine mammary tumours. J. Comp. Pathol. 2007, 136, 177-185.
• 13. Rothwell T. L., Howlett C. R., Middleton D. J., Griffiths D. A., Duff B. C.: Skin neoplasms of dogs in Sydney. Aust. Vet. J. 1987, 64, 161-164.
• 14. Thorén S., Jakobsson P. J.: Coordinate up- and down-regulation of glutathione- dependent prostaglandin E synthase and cyclooxygenase-2 in A549 cells. Inhibition by NS-398 and leukotriene C4. Eur. J. Biochem. 2000, 267, 6428- -6434.
• 15. Vascellari M., Giantin M., Capello K., Carminato A., Morello E. M., VercelliA., Granato A., Buracco P., Dacasto M., Mutinelli F.: Expression of Ki67, BCL-2,and COX-2 in canine cutaneous mast cell tumors: association with gradingand prognosis. Vet. Pathol. 2013, 50, 110-121.
• 16. Williams C. S., Mann M., DuBois R. N.: The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999, 20, 7908-7916